Your plasma donation eligibility varies based on the diabetes type, the control measures in use, and the treatment regimen followed
His A1c has decreased to 5.6%
Studies have found that the majority of people who start taking GLP-1s stop taking them within a year, and after stopping, about half begin to take the drug again
Micro-Infusion focuses on improving the skins appearance by creating micro-channels on the skins surface
For comparison, at a peak of GLP-1 dispensing in early 2023, young women (18-25 years old) were given 45,000 doses compared to less than 15,000 doses to young men (18-25 years old)
Matt Kaeberlein, the Chief Executive Officer of Optus Span Inc., an affiliate professor at the University of Washington, and a co-founder of the Dog Aging Project